167 related articles for article (PubMed ID: 2972795)
1. Presentation of the H-Y antigen on Langerhans' cell-negative corneal grafts downregulates the cytotoxic T cell response and converts responder strain mice into phenotypic nonresponders.
Peeler JS; Callanan DG; Luckenbach MW; Niederkorn JY
J Exp Med; 1988 Nov; 168(5):1749-66. PubMed ID: 2972795
[TBL] [Abstract][Full Text] [Related]
2. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
Peeler JS; Niederkorn JY
J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
[TBL] [Abstract][Full Text] [Related]
3. Helper effects required during in vivo priming for a cytolytic response to the H-Y antigen in nonresponder mice.
Juretić A; Malenica B; Juretić E; Klein J; Nagy ZA
J Immunol; 1985 Mar; 134(3):1408-14. PubMed ID: 2578505
[TBL] [Abstract][Full Text] [Related]
4. On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens.
Pion S; Fontaine P; Desaulniers M; Jutras J; Filep JG; Perreault C
Eur J Immunol; 1997 Feb; 27(2):421-30. PubMed ID: 9045913
[TBL] [Abstract][Full Text] [Related]
5. Abolition of specific immune response defect by immunization with dendritic cells.
Boog CJ; Kast WM; Timmers HT; Boes J; de Waal LP; Melief CJ
Nature; 1985 Nov 7-13; 318(6041):59-62. PubMed ID: 2932649
[TBL] [Abstract][Full Text] [Related]
6. Stimulation with dendritic cells decreases or obviates the CD4+ helper cell requirement in cytotoxic T lymphocyte responses.
Boog CJ; Boes J; Melief CJ
Eur J Immunol; 1988 Feb; 18(2):219-23. PubMed ID: 2965021
[TBL] [Abstract][Full Text] [Related]
7. Helper T cells for cytotoxic T lymphocytes need not be I region restricted.
Raulet DH; Bevan MJ
J Exp Med; 1982 Jun; 155(6):1766-84. PubMed ID: 6176668
[TBL] [Abstract][Full Text] [Related]
8. Effect of Langerhans' cells on cytotoxic T lymphocyte responses to major and minor alloantigens expressed on heterotopic corneal allografts.
Peeler JS; Niederkorn JY
Transplant Proc; 1987 Feb; 19(1 Pt 1):316-9. PubMed ID: 3547821
[No Abstract] [Full Text] [Related]
9. Epidermal cells as accessory cells in the generation of allo-reactive and hapten-specific cytotoxic T lymphocyte (CTL) responses.
Steiner G; Wolff K; Pehamberger H; Stingl G
J Immunol; 1985 Feb; 134(2):736-41. PubMed ID: 2578162
[TBL] [Abstract][Full Text] [Related]
10. Nonresponsiveness to the male antigen H-Y in H-2 I-A-mutant B6.C-H-2bm12 is not caused by defective antigen presentation.
de Waal LP; de Hoop J; Stukart MJ; Gleichmann H; Melvold RW; Melief CJ
J Immunol; 1983 Feb; 130(2):655-60. PubMed ID: 6401303
[TBL] [Abstract][Full Text] [Related]
11. Linked recognition of helper and cytotoxic antigenic determinants for the generation of cytotoxic T lymphocytes.
Cassell D; Forman J
Ann N Y Acad Sci; 1988; 532():51-60. PubMed ID: 2460011
[TBL] [Abstract][Full Text] [Related]
12. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes.
Keene JA; Forman J
J Exp Med; 1982 Mar; 155(3):768-82. PubMed ID: 6801178
[TBL] [Abstract][Full Text] [Related]
13. The immunogenic privilege of corneal allografts.
Niederkorn JY; Peeler JS; Ross J; Callanan D
Reg Immunol; 1989; 2(2):117-24. PubMed ID: 2701814
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T lymphocyte nonresponsiveness to the male antigen H-Y in the H-2Db mutants bm13 and bm14. Complementation of the response in F1 crosses with the I-Ab mutant bm12 nonresponder and failure of B6 or Db mutant mice tolerant of each other to respond to allogeneic male cells.
De Waal LP; Melvold RW; Melief CJ
J Exp Med; 1983 Nov; 158(5):1537-46. PubMed ID: 6415206
[TBL] [Abstract][Full Text] [Related]
15. Immunodominance in the T cell response to multiple non-H-2 histocompatibility antigens. III. Single histocompatibility antigens dominate the male antigen.
Wettstein PJ
J Immunol; 1986 Oct; 137(7):2073-9. PubMed ID: 3489751
[TBL] [Abstract][Full Text] [Related]
16. T-cell responses to minor histocompatibility antigens.
Lai PK; Waterfield JD; Gascoigne NR; Sharrock CE; Mitchison NA
Immunology; 1982 Oct; 47(2):371-81. PubMed ID: 6214502
[TBL] [Abstract][Full Text] [Related]
17. Cross presentation of antigen on MHC class II via the draining lymph node after corneal transplantation in mice.
Kuffová L; Netuková M; Duncan L; Porter A; Stockinger B; Forrester JV
J Immunol; 2008 Feb; 180(3):1353-61. PubMed ID: 18209029
[TBL] [Abstract][Full Text] [Related]
18. Preservation of donor cornea prevents corneal allograft rejection by inhibiting induction of alloimmunity.
Kamiya K; Hori J; Kagaya F; Usui T; Amano S; Oshika T; Mizouchi T; Tsuru T; Yamagami S
Exp Eye Res; 2000 Jun; 70(6):737-43. PubMed ID: 10843778
[TBL] [Abstract][Full Text] [Related]
19. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition.
Sano Y; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658
[TBL] [Abstract][Full Text] [Related]
20. The ability of Ia and H-2Kk-bearing membranes to replace the antigen-presenting cell in an H-2Kk allogeneic cytotoxic T cell response.
Weinberger O; Herrmann SH; Greenstein JL; Mescher MF; Burakoff SJ
Eur J Immunol; 1985 Oct; 15(10):1013-8. PubMed ID: 2932336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
